News
COVID-19 VACCINE FOR 18 ABOVE BEGINS FROM 1 MAY

COVID-19 VACCINE FOR 18 ABOVE BEGINS FROM 1 MAY

Currently, The Covid-19 Vaccine C only citizens above the age of 45 were allowed to take the vaccine, but on Monday the government of India has announced, “all citizens aged above 18 will be eligible for vaccination starting May 1″.

Vaccination will continue in government centres free of cost for those eligible, including healthcare and frontline workers and anyone who is 45 or more.

MyGovindia has tweeted  Registration for 3rd phase of the vaccine will start from 28th April through the Cowin platform and Aarogya Setu App. Everyone above the age of 18 years will be eligible to get vaccinated against the coronavirus.

In a meeting chaired by Prime Minister Narendra Modi, liberalised and accelerated Phase 3 strategy of Covid-19 vaccination’,” the government has permitted vaccine manufacturers to release up to 50 per cent of their supply to state governments and in the open market at a pre-declared price”. Based on this price, state governments, private hospitals, industrial establishments etc would be able to procure vaccine doses from the manufacturer

 

Manufacturers would transparently make an advance declaration of the price for 50% supply that would be available to state governments and in the open market, before May 1. Private vaccination providers shall transparently declare their self-set vaccination price. The eligibility through this channel would be opened up to all adults, i.e. everyone above the age of 18.

The division of vaccine supply – 50% to Government of India and 50% to other than Government of India channel would be applicable uniformly across for all vaccines manufactured in the country.

Wastage of vaccine will also be considered in this criterion and will affect the criteria negatively. Based on the above criteria, State-wise quota would be decided and communicated to the States adequately in advance.

The second dose of all existing priority groups and population above 45 years, wherever it has become due, would be given priority, for which a specific and focused strategy would be communicated to all stakeholders.

The vaccination drive currently offers two COVID-19 vaccines – Covaxin that has been developed by Hyderabad-based Bharat Biotech and Covishield that has been developed by the Oxford-AstraZeneca and is being manufactured by the Serum Institute of India (SII).

 

The Normal  Circular  Stage of a  Covid-19 vaccine are:

 

Exploratory stage

Pre-clinical stage

Clinical development

Regulatory review and approval

Manufacturing

Quality control

 

In the race to discover an effective vaccine against the deadly coronavirus, Pfizer was the first to release a late-stage trial preliminary results. Developed in partnership with Germany’s BioNTech SE Pfizer’s mRNA-based vaccine, BNT162b2, has more than 90% efficacy, around 95% with trials held across 6 countries.

Pfizer/BioNtech vaccine is an mRNA vaccine meaning, it uses an experimental approach where a slice of the virus’s genetic code is injected into the body so as to train the immune system to fight it. It does so by producing the coronavirus spike protein, prompting the production of T-cells and antibodies that destroy the infected cells.

Volunteers reported that the side effect of the vaccine was synonymous with a “severe hangover” where they had a bit of headache, fever, and muscle ache. While effective in reducing transmission and stopping development, it is yet unknown how long this vaccine is effective after the second dose.

Covid-19 Vaccine

 

How do we make sure Covid-19 vaccines are safe?

Any vaccine approved for use in the UK must go through a robust and rigorous testing process to make sure that it meets extremely high standards of safety, quality and efficacy.

Public safety always comes first and vaccines are only made available to the public when they have met strict criteria.

Vaccines, like all medicines, are highly regulated and there are checks carried out at every stage of development to ensure safety is not compromised at any point.

Once a vaccine has been developed, it is given to a small group of volunteers in a clinical trial to assess initial safety. Next, it is given to a bigger group of people, usually hundreds, to learn more about its safety and to see if an immune response is triggered. Then the trial is expanded to thousands of people and the number of people who get the disease in those vaccinated is compared to a group who did not receive the vaccine, so we can report on its safety and efficacy.

The Pfizer/BioNtech vaccine was given to 43,500 people during its clinical trial and no major side effects or safety concerns have been reported.

 

What about COVID-19  Vaccine variants?

We are making efforts to understand the effect of the variants on the vaccine and there is currently no evidence to that Prove that vaccines will be ineffective.

We know that the vaccines currently in use are likely to have at least 60% protection against the variant first identified in South Africa, which is very Dominant.  This is An equivalent to flu vaccination.

We will learn more about this as the population studied in South Africa throughout their vaccination.

There are a number of studies taking place at the moment including an AstraZeneca trial taking place in South Africa and we will continue to monitor the situation.

What role does a vaccine play in ending the pandemic?

Effective vaccines are a  part of ending the COVID-19 pandemic. Through vaccination, we can stop those risk from the virus, meaning a reduction in hospitalizations and more deaths. However, a vaccine is not a ‘Golden Gift ’ and won’t stop the pandemic immediately.

It will take time and a continuation of Re-Opening will increase the spread, we should follow such as Rules: social distancing and washing hands, a vaccine and a deeper understanding of the virus that only comes with time. Taking Precaution and Proper diet will help reduce The Covid Rate and death Rate in hospitals.

 

How do Covid-19 vaccines work?

Vaccines contain either a weakened or dead version of the virus or a part of the virus,  which cannot harm the recipient.

When we receive The vaccine, it helps our immune system to produce antibodies like it would if we are infected with the Covid Virus. These antibodies remain in our body And Help US to fight against that virus, so if we get connect Touch to the virus in future, we can quickly fight Against the disease before we become ill.

 

COVID vaccine trials – where are we at now?

Of course, the point of vaccine development is to harmlessly expose parts of the virus to the immune system, which then recognizes it as an invader and develops a fighting mechanism. Preparing a vaccine undergoes several stages of development, from exploration to trial to manufacturing and market distribution.

 

How get register for a vaccine online?

The registration process for phase 3 begins from 28th April, the users can use CoWIN portal and Aargya Setu app to register for the vaccine.

CoWIN Registration:

  1. Log on to cowin.gov.in and click on Register/Sign in Yourself
  2. Enter your mobile number, click on Get OTP. An OTP will be sent to your entered number.
  3. Enter OTP, click on verify button.

Then validated, the Registration of Vaccination page will open up.

  1. Enter all the details, including photo ID proof, name, gender, and year of birth Feed-in details of comorbidities if you have, once done, click on Register.

Once registration is done, you will be shown Account Details. You can schedule your appointment from the Account Details page.

  1. You will get the option to schedule an appointment, Click on Schedule next to the name of the person registered.
  2. Enter your pin code and hit Search. The centres in the pin code will show up, select the date and time and click on Confirm.

**You can add up to four members through one login, all you have to do is press Add More button at the bottom right side of the page and enter all the details. It is easy to reschedule your appointment; the process is similar to how you schedule it**.

Aarogya Setu app:

  1. Download Aarogya Setu app and open it.
  2. Click on CoWIN tab on the home screen.
  3. Select Vaccination Registration.
  4. Then Enter the Phone Number.
  5. Then enter OTP you received on your phone number and click verify.

You will be directed to the Registration of Vaccination page

  1. Enter all the details, including photo ID proof, name, gender, and year of birth Feed-in details of comorbidities if you have, once done, click on Register.

Once registration is done, you will be shown Account Details. You can schedule your appointment from the Account Details page.

  1. You will get the option to schedule an appointment, Click on Schedule next to the name of the person registered.
  2. Enter your pin code and hit Search. The centres in the pin code will show up, select the date and time and click on Confirm.

**You can add up to four members through one login, all you have to do is press Add More button at the bottom right side of the page and enter all the details. It is easy to reschedule your appointment; the process is similar to how you schedule it**.

 

Each citizen has to take two shots of the vaccine. The CoWIN portal says that the second dose of Covaxin should be taken between 28 days to 42 days after the first dose. The second dose of Covishield should be taken between 28 days to 56 days after the first dose.

For More Latest  Updates And Information Regarding Covid-19 You Just Visit By Clicking This Link :

https://www.bloggbuzz.com/category/news/

 

 

Leave a Reply